对低风险个体进行肺癌筛查:需求可能存在,但获益证据不足
全球肺癌死亡率高,晚期预后差,早期检出可改善结局,高质量筛查净获益良好。已证实对高危人群每年低剂量CT筛查可降低死亡率,因此有观点认为该获益可推广至从不吸烟者。亚洲多项大规模单臂观察性试验显示,轻度或无吸烟史者(伴或不伴肺癌家族史)的肺癌检出率高于既往报告的高危吸烟者。台湾近5万人早期检测项目显示,有家族史的轻度或不吸烟者低剂量CT筛查的肺癌检出率是符合USPSTF筛查标准且吸烟≥30包年高危者的两倍以上,且家族史者检出癌症中90%以上为早期。作者认为这些发现代表 substantial overdiagnosis,低致命癌症风险人群筛查的危害未被充分考虑,并就此提出观点。
要点
- 高危人群低剂量CT筛查可降低肺癌死亡率,但低风险人群获益证据不足。
- 台湾近5万人项目显示有家族史轻度/不吸烟者检出率为高危吸烟者两倍以上,早期占90%以上。
- 作者认为这些发现代表过度诊断,低风险人群筛查的危害未被充分评估。
核心结论
- 作者认为低风险人群(从不吸烟或轻度吸烟、有家族史)肺癌筛查的获益证据不足,相关发现代表过度诊断,筛查危害未被充分考虑。
研究设计与样本
- 本文为观点性文章,评述亚洲多项大规模单臂观察性试验及台湾近5万人肺癌早期检测项目的结果。
主要发现
- 台湾近5万人项目中,有家族史的轻度或不吸烟者低剂量CT筛查的肺癌检出率是符合USPSTF标准且吸烟≥30包年高危者的两倍以上。
- 有家族史者检出的癌症中90%以上为早期。
- 亚洲多项单臂观察性试验显示轻度至无吸烟史者(伴或不伴家族史)的肺癌检出率高于既往报告的高危吸烟者。
关键数值与推荐
- 原文未给出具体筛查推荐标准或数值阈值。
临床怎么用
- 原文未据此给出临床推荐,作者认为对低风险人群筛查的获益证据不足且危害未被充分评估。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Worldwide, lung cancer is the most common killer among cancers, advanced disease has worse outcomes, earlier stage detection leads to better outcomes, and high-quality screening has a favorable net benefit. With the mortality reduction recognized from annual low-radiation dose computed tomography by screening those at high risk, there has been consideration that this benefit could translate to those who have never smoked. There have been several large-scale, single-arm, observational trials in Asia in persons with light to no smoking histories, with or without a family history of lung cancer, which have revealed high or higher lung cancer detection rates than previously reported in high-risk persons who currently or formerly smoked. The Early Detection Program for Lung Cancer in Taiwan, of nearly 50,000 persons, revealed that the cancer detection rate for those screened with low-radiation dose computed tomography was more than twofold higher in light- or never-smokers with a family history of lung cancer compared with high-risk persons with more than 30 or more pack-years exposure and meeting U.S. Preventative Services Task Force criteria for screening. In addition, more than 90% of the cancers detected in those with a family history were in early stage. On the basis of those findings, the researchers concluded that screening first-degree relatives of those with a family history of lung cancer, irrespective of smoking history, would lead to a decrease in lung cancer mortality. We believe that the findings in this cohort and others like it represent substantial overdiagnosis and that the harms associated with screening a population that has a low likelihood of developing lethal cancers have not been thoroughly considered. Here, we provide our perspective and consider the potential benefits and harms of screening populations outside those currently eligible using the U.S. Preventative Services Task Force criteria.
引用
- Silvestri GA, Young RP, Tanner NT, et al. Screening Low-Risk Individuals for Lung Cancer: The Need May Be Present, but the Evidence of Benefit Is Not. J Thorac Oncol. 2024. PMID: 39112003. doi:10.1016/j.jtho.2024.05.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。